Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Akers Biosciences, Inc.

TRADE

NASDAQ: AKERHealthcare / Medical Instruments & Supplies / USA
2.20-0.26-10.57%Vol 461 6461Y Perf -65.19%
Nov 14th, 2018 15:06
BID2.19 ASK2.20
Open2.39 Previous Close2.46
Pre-Market2.53 After-Trading2.35
 0.07 2.85%  -0.11 -4.47%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)26 
Earnings Rating
Buy
Price Range Ratio 52wk %
18.02 
Earnings Date
21st Nov 2018

Today's Price Range

2.152.50

 

52wk Range

0.967.84

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
602.86%
3 Months
720.00%
6 Months
459.09%
1 Year
-65.19%
3 Years
28.13%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
AKER2.20-0.2600-10.57
AAPL188.52-3.7100-1.93
GOOG1 051.3615.31001.48
MSFT106.42-0.5200-0.49
XOM77.60-0.4000-0.51
WFC52.26-0.4800-0.91
JNJ144.980.30000.21
FB145.052.89002.03
GE8.34-0.2700-3.14
JPM107.70-1.8900-1.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.70
Current Ratio 5.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2 430.30
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin51.30
EBIT Margin-227.80
EBITDA Margin-219.80
Pre-tax Profit Margin-165.10
Profit Margin-83.41
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 25.61
PS Ratios 12.36
Price to Cash Flow 44.60
Price to Free Cash Flow -52.20
Cash Flow Per Share -0.54
Price to Tangible Book28.35
Book Value per Share0.92
Enterprise Value (in ths.)19 625
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-73.90
ROE last 12 Months -95.10
Return on Assets (5Y Avg) -51.33
ROA last 12 Months -78.77
Return on Capital (5Y Avg) -66.27
ROC last 12 Months -96.23
Return on invested Capital Q -19.05
Return on invested Capital Y-108.24
Assets Turnover0.10
Receivables Turnover1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 255
Revenue per Share 0.19
Revenue Growth 3 Years 5.19
Revenue Growth 5 Years -4.30
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.19-
Q01 2016--0.28-
Q04 2015--0.69-
Q03 2015--0.36-
Q02 2015--0.41-
Q01 2015--0.26-
Q04 2014--0.19-
Q03 2014--0.23-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date21st Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume461 646
Shares Outstanding (in ths.)11 760
Trades Count1 457
Dollar Volume943 959
Avg. Volume1 079 491
Avg. Weekly Volume805 038
Avg. Monthly Volume762 854
Avg. Quarterly Volume552 210

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

74%26%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x